Penn Engineers have redesigned the lipid nanoparticles (LNPs) used to deliver mRNA vaccines, showing that subtle changes in lipid chemistry can influence immune cell metabolism and reduce inflammation ...

Acurastem received a grant to develop ALS therapies targeting SYF2, a regulator of TDP-43, in collaboration with academic research teams.

Faced with his dog's cancer, Australian entrepreneur Paul Conyngham decided to try an unusual approach. He claims to have used artificial intelligence and genetic analysis to design a personalized ...

The tale of this heartbroken tech entrepreneur, his tumour-riddled rescue dog and a cure for cancer has leading scientists astounded.

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

Sydney consultant uses ChatGPT and AI tools to design mRNA cancer vaccine that shrunk his dog's tumor by half in breakthrough case.

Silicon nanotube arrays deliver functional mRNA into human pluripotent stem cells for the first time, achieving up to 64% transfection without compromising stem cell identity.

With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...

A man successfully developed a mRNA cancer vaccine for his dog with the help of AI, and medical science is stunned.

Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution.

An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed ...

A remarkably small bacterium containing fewer than 500 genes serves as the basis for one of the most detailed digital life reconstructions ever created. Using computer technology, scientists have ...